XML 42 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
CAPITAL STOCK
3 Months Ended
Mar. 31, 2013
Notes to Financial Statements  
CAPITAL STOCK

4. CAPITAL STOCK

 

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model, with the following weighted average assumptions for options granted in the three months ended March 31, 2012 and 2013.

 

     

Three Months Ended

March 31,

          2012   2013
                       
Risk-free interest rate           0.56%    0.54%
Expected lives           3.0 years    3.4 years
Expected volatility           60%    52%
Expected dividend yield           3.43%    0.00%
                           

 

A summary of the Company's stock option plans, excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split is as follows:

 

 

Year Ended

December 31, 2012

Three Months Ended

March 31, 2013

 

 

 

 

 

Options

 

Weighted

Average

Exercise

Price

 

 

 

 

 

Options

 

Weighted

Average

Exercise

Price

Outstanding at beginning of period   1,448,675    $ 10.425      1,245,161    $ 11.054   
  Granted at market   137,950    $ 9.534      31,230    $ 8.344   
  Cancelled   (118,330 )   $ 11.373      (13,758)    $ 5.101   
  Exercised   (223,134 )   $ 5.863      (17,752)    $ 6.430   
Outstanding at end of period   1,245,161    $ 11.054      1,244,881    $ 11.118   
Exercisable at end of period   971,029    $ 12.129      966,038    $ 12.191   

 

The estimated fair value of stock options granted during the three months ended March 31, 2013 and 2012 was computed to be approximately $97 thousand and $13 thousand, respectively. The amount is amortized ratably over the vesting period of the options. The per share weighted average estimated fair value of options granted during the three months ended March 31, 2013 and 2012 was computed to be approximately $3.13 and $3.91, respectively. The total intrinsic value of options exercised during the three months ended March 31, 2013 and 2012 was approximately $35 thousand and $652 thousand, respectively. The cash proceeds from options exercised during the three months ended March 31, 2013 and 2012 were approximately $84 thousand and $184 thousand, respectively.

 

The following table summarizes information about stock options outstanding and exercisable at March 31, 2013, excluding outstanding options to purchase an aggregate of 105.1 fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split with a weighted average remaining contractual life of 1.63 years, a weighted average exercise price of $13.71 and exercise prices ranging from $4.40 to $31.50. The Company intends to issue whole shares only from option exercises.

 

  Options Outstanding Options Exercisable  
Exercise Prices Number of
Options
Outstanding
at
March 31,
2013
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Exercise
Price
Number of
Options
Exercisable
at
March 31,
2013
Weighted
Average
Exercise
Price
 
$ 2.70 - $ 6.76   258,803      5.76    $ 5.229      189,533    $ 5.131   
$ 6.77 - $ 8.55   259,423      8.19    $ 7.811      63,035    $ 7.513   
$ 8.56 - $12.40   259,272      3.23    $ 9.587      246,087    $ 9.575   
$12.41 - $16.50   237,811      2.08    $ 14.051      237,811    $ 14.051   
$16.51 - $31.50   229,572      2.47    $ 20.182      229,572    $ 20.182   
$ 2.70 - $31.50   1,244,881      4.43    $ 11.118      966,038    $ 12.191   
                                     

 

As of March 31, 2013, there was approximately $646 thousand of total unrecognized compensation cost related to outstanding stock options. That cost is expected to be recognized over a weighted average period of 2.0 years, with approximately $236 thousand to be recognized in the nine months ending December 31, 2013 and all the cost to be recognized as of February 2017, assuming all options vest according to the vesting schedules in place at March 31, 2013. As of March 31, 2013, the aggregate intrinsic value of outstanding options was approximately $1.5 million and the aggregate intrinsic value of exercisable options was approximately $984 thousand.